Kelt, this post is for you. I know you were instrumental
Kelt, this post is for you.
I know you were instrumental in either leading others to CTIX or helping them in the early stages of CTIX realize it's value. One of those was me! You helped many of us acquire significant positions at very attractive entry prices and if all goes as expected we will become pretty wealthy.
I find it quite disturbing that due to bad luck in health and family matters you have had to divest yourself of much of your holdings and will not reap the benefits from CTIX that you deserve.
If things go well and I get wealthy, one of my dreams I will realize is to become a secret Santa. Well, I think you should be one of the first to benefit from same so once CTIX hits $10 I will sell you some of my stock at the cost I paid for it. This stock is currently in my regular fully taxed account and my purchase price is under $1. I make nothing I will have to pay taxes on and you get to reap almost the entire amount you would have made if your luck had not turned so poorly. I know this is not being a Secret santa but the next paragraph explains why I am posting this in public.
I hope others will take note of this idea as many on this board should hold significant amounts of CTIX and maybe they will let go of some of their stock with the same stipulations as I am. If we each provide you with a bit of stock, in toto you could regain most of your stash and each of us will be out not that much.
I have to put the $10 min on the deal as I owe it to my wife not to give away some of our holdings until I know we are financially secure for the future. I really don't see that price figure being a problem as it looks like CTIX is about to start blowing and going.
My email is petemantx@charter.net.
In a week or two, giving enough time for maybe others to get in touch with you, send me an email and let me know how much of your stock you had to liquidate, if anyone else is chipping in, and I will let you know how much stock I can afford to sell you (in a direct sale thru the transfer agent if that is legal). I have two other plays going right now that I think should be big money makers over the next 3 months and if they increase my cash flow significantly and I can purchase more CTIX than I ever previously had, I will be able to provide you with even a larger amount of stock.
This way, you now know you will be participating in CTIX just as you had planned before the bad luck came your way.
Expect to hear from you within a month. I know I had your email but I had to change my whole computer setup and lost all my contacts.
Hope we can all join and minimize your loss with just a small input from a handful of friends.
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...
Continue Reading
Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...
Continue Reading
Preserving Our Natural Chompers Digging into the details of endodontic care, you realize how it's the unsung hero in the dental world. And let's face it, teeth don't get happier on their own when there's a problem on the inside. Dr. Christopher Joubert, a wiz on the endodontic front, spills the beans over at HelloNation about how essential these practices are in keeping...
Continue Reading
Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...
Continue Reading
ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...
Continue Reading
Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...
Continue Reading
Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...
Continue Reading
Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...
Continue Reading
China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...
Continue Reading
Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...
Continue Reading
Top 5 Most Recently Viewed Articles
Cingulate Inc. Announced Financial Highlights for Q2 2025 Cingulate Inc. (NASDAQ: CING), a prominent biopharmaceutical company focused on innovative ADHD treatments, recently disclosed its financial results for the second quarter of 2025, alongside significant advancements. Central to the company’s activities was the submission of the New Drug Application (NDA) for its...
Continue Reading
Investment Growth Over Five Years Investing wisely can create remarkable returns over time. A case in point is Carvana Co (NASDAQ: CVNA), which has significantly outperformed expectations in recent years. Over the past five years, Carvana has shown an impressive annualized return of 18.46%, surpassing the market by 4.39% each year. Presently, Carvana's market...
Continue Reading
Deko Cocktails Achieves WSWA Best RTD Award Deko Cocktails, a newly launched line of expertly crafted ready-to-serve cocktails, recently secured a prestigious accolade in the beverage alcohol industry. The company was honored with the Best RTD (Ready to Drink) Product of the Year at the Wine & Spirit Wholesalers of America (WSWA) Brand Battle. This annual competition...
Continue Reading
Key Insights on Bouygues SA's Monthly Share and Voting Rights Bouygues SA regularly updates its shareholders about essential metrics, including the total number of shares and the voting rights attached to them. Understanding these details is vital for investors and stakeholders who wish to stay informed of the company's standing in the market. Transparency in Shareholder...
Continue Reading
Oncternal Therapeutics Inc. (ONCT) was in dire straits back then, hitting a notable low of $1.31 amidst a turbulent market that left investors biting their nails. This stock plunge represented a hefty drop of -76.33%, rattling traders who were already on edge over the biopharmaceutical company’s struggle to bring innovative cancer therapies to market. The company's...
Continue Reading